Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Distinguishing Chronic Inflammatory Demyelinating Polyneuropathy From Mimic Disorders: The Role of Statistical Modeling.
Swart G, Skolka MP, Shelly S, Lewis RA, Allen JA, Dubey D, Niu Z, Spies J, Laughlin RS, Thakolwiboon S, Santilli AR, Rashed H, Mirman I, Swart A, Berini SE, Shouman K, Pinto MV, Mauermann ML, Mills JR, Dyck PJB, Harmsen WS, Mandrekar J, Klein CJ. Swart G, et al. Among authors: allen ja. J Peripher Nerv Syst. 2025 Mar;30(1):e12682. doi: 10.1111/jns.12682. J Peripher Nerv Syst. 2025. PMID: 39801067
Inflammatory Neuropathy Consortium base (INCbase): a protocol of a global prospective observational cohort study for the development of a prediction model for treatment response in chronic inflammatory demyelinating polyneuropathy.
Michael MR, Wieske L, Allen JA, Lunn MP, Doppler K, Tan CY, Koike H, Markvardsen LK, Kapoor M, Hsieh ST, Nobile-Orazio E, Jacobs BC, Rajabally YA, Basta I, Ripellino P, Querol L, Eftimov F; INCbase Consortium. Michael MR, et al. Among authors: allen ja. BMC Neurol. 2024 Oct 25;24(1):415. doi: 10.1186/s12883-024-03903-w. BMC Neurol. 2024. PMID: 39455929 Free PMC article.
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
Intrinsic aerobic capacity modulates Alzheimer's disease pathological hallmarks, brain mitochondrial function and proteome during aging.
Kugler BA, Lysaker CR, Franczak E, Hauger BM, Csikos V, Stopperan JA, Allen JA, Stanford JA, Koch LG, Britton SL, Thyfault JP, Wilkins HM. Kugler BA, et al. Among authors: allen ja. Geroscience. 2024 Oct;46(5):4955-4967. doi: 10.1007/s11357-024-01248-3. Epub 2024 Jun 13. Geroscience. 2024. PMID: 38867031 Free PMC article.
370 results